Showing posts with label Diabetes. Show all posts
Showing posts with label Diabetes. Show all posts

Monday, 6 March 2017

Treatment of Diabetes

Independent TD Thomas Pringle told the Dáil that €800 million could be saved on the treatment of diabetes, if patients had access to insulin pumps.

He said there are 666 patients in County Donegal with Type 1 diabetes, but only 20 have access to insulin pumps and that €1.3bn a year was spent on treating diabetes with €800 million on treating complications.
The Tánaiste said she would ask the Minister for Health to liaise directly with Mr. Pringle regarding the situation in County Donegal and added that additional funding had been given to primary care centres, for specialist interventions in diabetes.


Image result for diabetes pump

Wednesday, 8 February 2017

BMI Linked to Memory Impairment

Lucy Cheke and her colleagues at the University of Cambridge recently invited a few participants into her laboratory for a kind of ‘treasure hunt’.

The participants navigated a virtual environment on a computer screen, dropping off various objects along their way. They then answered a series of questions to test their memory of the task, such as where they had hidden a particular object.
When examining what might have influenced their performance, you might expect that Cheke would have been more concerned with the participant’s IQ – not their waistline. Yet she found a clear relationship between their Body Mass Index – a measure of your weight relative to your height – and apparent memory deficits: the higher a participant’s BMI, the worse they performed on the Treasure Hunt task.
In doing so, Cheke has contributed to a small but growing body of evidence showing that obesity is linked to brain shrinkage and memory deficits. This research suggests that obesity may contribute to the development of neurodegenerative conditions such as Alzheimer’s Disease.
Surprisingly, it also seems to show that the relationship between obesity and memory is a two-way street: being overweight or obese not only impacts on memory function, but may also affect future eating behaviour by altering our recollections of previous eating experiences.

Cheke’s interest in the subject began unexpectedly. “At the time I was looking at the ability to imagine a future state, particularly in terms of making decisions about food,” says Cheke. “If you’re hungry, you’ll imagine your future self as being hungry, too, but obese people seem to make such decisions on fact-based judgements rather than imagining.”
One possibility was that the obesity might have been damaging their capacity for “mental time travel”. Scientific research has long shown that memory and imagination are intimately linked, as we piece together fragments of past recollections to predict how future events might pan out.
The link made sense, she says, with some signs that obesity affects areas of the brain known to be used in memory and imagination. In 2010, for instance, researchers at Boston University School of Medicine reported that healthy, middle-aged adults with increased abdominal fat tend to have slightly lower overall brain volume. In particular, the hippocampus, a deep brain structure sometimes called the brain’s printing press thanks to its role learning and memory, was significantly smaller in obese people compared to leaner individuals.
There were also some hints from animal studies. “In studies focusing on weight changes and eating behaviours in rodents, the animals were terrible at learning tasks such as the Morris water maze,” explains Cheke. “The more I looked into it, the more I expected to see memory deficits, but that question was still very much open.”
Hence her experiment with the treasure hunt. Sure enough the obese participants found it particularly difficult to remember the location of the different objects – adding some important evidence for her hypothesis, and supporting earlier findings that indirectly linked obesity to impairments of cognitive function.

(Credit: Getty Images)
Overeating may cause long-term changes to the
brain, damaging our recall

More recently, a brain scanning study including more than 500 participants confirmed that being overweight or obese is associated with a greater degree of age-related brain degeneration. These effects were biggest in middle-aged people, in whom the obesity-related changes corresponded to an estimated increase in 'brain age' of 10 years.
Obesity is a complex condition with many contributing factors, however; so exactly how it might affect brain structure and function is still unclear.
“Body fat is the defining feature of obesity, but you’ve also got things like insulin resistance, hypertension, and high blood pressure,” says Cheke. “These can go hand in hand with behavioural factors [such as overeating and lack of exercise] and they can all potentially cause changes in the brain.”
“For example, insulin is an important neurotransmitter, and there’s a lot of evidence that diabetes is associated with changes in learning and memory,” she adds, “but there’s also evidence that high body fat on its own leads to inflammation in the brain, which can also cause problems.”
Inflammation is another potential culprit. Psychologists from the University of Arizona examined data from more than 20,000 participants in the English Longitudinal Ageing Study, in which measures of memory, BMI, and blood plasma levels of an inflammatory marker called C-reactive protein were collected every 2 years between 1998 and 2013.
They found that greater body mass was associated with a decline in memory function, and also with higher levels of the inflammatory protein. Although these links are indirect, the results suggest that brain inflammation is one plausible mechanism by which differences in body mass might influence cognitive function in otherwise healthy, aging adults.

Two-way Street
This should be of particular concern, given recent evidence that the path between memory and obesity may go both ways, as attention and memory control our appetite and eating behaviour. In other words, a deficit in your memory could cause you to gain weight.
Early evidence that memory plays an important role in eating behaviour came from a 1998 study showing that patients with severe amnesia will readily eat multiple meals one after the other, because they could not remember that they had just eaten.
“This shows that when we’re deciding how much to eat we’re not just basing those decisions on physiological signals about how much food there is in our stomach, but also on cognitive processes like memory,” says experimental psychologist Eric Robinson of the University of Liverpool.
“If your memory’s impaired or just not very good then you might overeat,” he adds. “I wanted to know if this could be reversed. If you improve a person’s memory, could that be a useful way of getting them to eat less?”

Wednesday, 7 December 2016

Body Fat Storage - Diabetes

 Inability to Store Fat Safely Increases Diabetes Risk

A study of 200,000 people showed that those with a variation in their genetic make-up were less likely to deposit fat under the skin in the lower body.
This can lead the body to become resistant to the hormone insulin.
The scientists said their findings explain why even slim people who eat too much and are inactive are at risk.
And they added that a healthy diet and physical exercise is important, regardless of body weight.

Measuring a patient's waist to see if she has excess fat around the internal organs

Genetic Link

Insulin is a hormone that controls levels of blood sugar.
When the body becomes resistant to it, levels of blood sugars and lipids rise, increasing the risk of diabetes and heart disease - but no-one is sure why insulin resistance happens and why some people become resistant when overweight, and others do not.
International figures show that 43% of people who develop type 2 diabetes are obese, 43% are overweight and 14% have a healthy weight.
The Cambridge study, published in Nature Genetics, found that a large proportion of the population has inherited some of 53 separate genetic variants that inhibit the storage of fat safely under the skin, particularly in the lower half of the body.
Their fat is more likely to end up in the bloodstream or stored in and around the body's central organs.
The study said people who have more of this genetic material are at much greater risk of type 2 diabetes - no matter what their BMI (body mass index) is.

Fat location

In the 20% of the population with the highest number of these genetic variants, their risk of diabetes rose by 39% compared to the 20% of the population with the lowest genetic risk.

People with fat storage problems can end up with fat accumulating in and around the liver, pancreas and muscles - where it causes insulin resistance and eventually type 2 diabetes.

Dr Luca Lotta, from the Medical Research Council epidemiology unit at the University of Cambridge, said that fat stored in the arms, legs and under the skin played an important role.
"Our results highlight the important biological role of peripheral fat tissue as a deposit of the surplus of energy due to overeating and lack of physical exercise."

Tuesday, 8 November 2016

Glucose Monitoring - New Device

A new constant glucose monitoring device for people with diabetes has been described as a major innovation by leading consultant, Professor Donal O'Shea.

The device uses a skin sensor, placed on the back of the upper arm and an electronic reader, to allow people monitor their diabetes, eliminating the need for traditional finger pricking and using test strips.
The device, available in Ireland from today,  provides a visual snapshot of glucose levels and trends for up to 14 days.
Around 225,000 people have diabetes in Ireland and around 16,000 of these have Type 1 diabetes and are insulin dependent.
The Freestyle Libre Flash Glucose Monitoring System is made by Abbott.

The Freestyle Libre Flash Glucose Monitoring System is made by Abbott
The Freestyle Libre Flash Glucose Monitoring System is made by Abbott

The sensor on the skin, about the size of a €2 coin, stays on the arm for two weeks and must then be replaced.
An electronic reader, smaller than a mobile phone, is held over the sensor for a reading at any time.
Professor O'Shea, who is consultant endocrinologist and physician at St Vincent's University Hospital, said the device would make monitoring of blood-sugar levels much easier and people could do it more frequently.
He said the immediate groups to whom it should be made available to first are all children with Type 1 diabetes, people with Type 1 diabetes who are on multiple insulin injections each day and pregnant women who have gestational diabetes.
The starter pack cost of two sensors and a reader is €169.90.
Thereafter each sensor costs €59.90 and a reader is €59.90.

Currently it is available for private patients only.
The device would need to undergo a health technology assessment first before the HSE would decide whether to cover it in the public health service.
The device can be used by adults and children aged four years and older, with the children supervised.

Monday, 18 April 2016

Beat Diabetes - WHO Designated Day

The theme of this year's World Health Day — Beat Diabetes!

Thumbnail image of Figure. Opens large image

This adds to a 2011 UN initiative to stem the rise in prevalence of diabetes by 2025, as well as to reduce premature deaths from non-communicable diseases, part of Sustainable Development Goal 3. In today's Lancet, the NCD Risk-Factor Collaboration (NCD-RisC) report that in 2014, an estimated 422 million people worldwide were living with diabetes—roughly a four-fold increase over the past 35 years. The NCD-RisC pooled data from 751 studies that measured either fasting plasma glucose or haemoglobin A1c to determine global and regional trends in diabetes prevalence. And, as Etienne Krug highlights in an accompanying Comment, these data “sound the alarm for large-scale, effective action”.
The outlook for some regions is promising, with almost no changes in age-adjusted prevalence reported for both men and women in north-western and south-western Europe from 1980 to 2014, remaining below 6% for women and 8% for men. By contrast, in 2014, prevalence was higher than 25% in some islands of Polynesia and Micronesia, and as high as 31% and 33% for men and women, respectively, in American Samoa, which are also regions with high rates of obesity. These divergent statistics clearly show that beating diabetes on a global scale cannot be achieved with a one-size-fits-all approach.
Coinciding with World Health Day this year, WHO released its first ever Global report on diabetes. It reveals that in 2012, a total of 3·7 million deaths were attributable to higher-than-optimal blood glucose levels. The report calls for multi-sectoral, population-based approaches to help reduce risk factors for diabetes in the general population, and recommends a life-course perspective that instils healthy eating and physical activity from an early age to prevent type 2 diabetes later in life. Importantly, regulation of marketing, trade, and agricultural policies to promote healthier eating is also proposed.
The tide toward prevention is beginning to turn, albeit slowly. Last month, the UK Government announced the roll-out of Healthier You: The NHS Diabetes Prevention Programme, which offers personalised lifestyle and behavioural modification advice to individuals at risk of developing type 2 diabetes. In 2016, 20 000 referrals will be offered across 27 regions, with nationwide coverage and 100 000 annual referrals expected by 2020. According to the US Department of Health and Human Services, a pilot diabetes prevention programme tested in nearly 8000 people has shown that lifestyle counselling that encourages healthy eating and exercise improvements can lead to weight loss and diabetes prevention. Encouragingly, this is the first programme in the USA to prove an economic case for diabetes prevention, with estimated savings of US$2650 per enrollee over a 15-month period. On this basis, the Obama Administration has proposed that the Diabetes Prevention Program be incorporated into Medicare for beneficiaries with pre-diabetes, as early as 2017.
Prevention is of utmost importance, but for the more than 420 million people currently living with diabetes, managing their disease must remain the priority. WHO's report recommends a multidisciplinary approach with patient education, medication, and consistent follow-up.

Furthermore, engaging patients in structured education programmes, such as DAFNE, for individuals with type 1 diabetes, improves life expectancy, diabetes-related complications, and hypoglycaemic awareness, and reduces the financial burden of disease management. Given that 80–90% of cases are type 2 diabetes, which is linked to obesity and lifestyle, structured self-management programmes that can be delivered to large numbers of patients are urgently needed.
We welcome such programmes, but more intensive efforts are needed. To this end, The Lancet and the Chinese University of Hong Kong announce a new Clinical Commission, led by Juliana Chan and Edward Gregg. The Commission will review available scientific evidence, analyse and evaluate existing policies to address diabetes, and devise a strategy and accountability framework for short, medium, and long-term solutions to address the growing unmet needs in diabetes prevention and control.
The massive increase in prevalence of diabetes, in particular type 2, is sobering. The NCD-RisC group estimates that if prevalence continues to rise at the rate of the past 15 years, the probability of halting global diabetes prevalence at 2010 levels by 2025 is less than 1%. Worldwide, the number of adults with diabetes will surpass 700 million. World Health Day 2016 is a prime opportunity for patients, the community, health-care providers, and policy makers to refocus efforts to end the diabetes epidemic. Immediate action is needed to avert this escalating health disaster.

Friday, 8 April 2016

Obesity Update (2)

Anaerobic Exercise:
Anaerobic exercise comprises brief, strength-based activities, such as sprinting or bodybuilding, whereas aerobic exercise is centered around endurance activities, such as marathon running or long-distance cycling. However, the early stage of all exercise is anaerobic.
Examples of anaerobic exercise include weight lifting, sprinting, and jumping; any exercise that consists of short exertion, high-intensity movement, is an anaerobic exercise.



Dr. Donal O’ Shea   Dr. Donal  O’ Shea

Consultant Endocrinologist and Joint Chair of RCPI Obesity Policy Group:

Donal O’Shea qualified from University College Dublin in 1989. He moved to Hammersmith Hospital in London and worked as a Registrar in General Medicine, Cardiology and Endocrinology before being appointed as Senior Registrar in Endocrinology. He was awarded a Wellcome Trust Training Fellowship to study the hypothalamic control of appetite. In 1996, he was appointed as Consultant Physician/Senior Lecturer in Diabetes and Endocrinology at Charing Cross Hospital, London.
In 1999, he moved to his current position in St Vincent’s University and St Columcille’s Hospitals, Dublin where he runs a hospital based multidisciplinary treatment unit for the management of adult obesity. He chaired the Detection and Treatment subgroup of the National Obesity Taskforce in 2005, chairs the nutrition council of the Irish Heart Foundation and was appointed associate Professor of Medicine in UCD in 2007.

Thursday, 4 February 2016

Recent Acquisitions


Located at 618.97683 WEL












Located at 618.92462 EDG












Located at 618.92853 LAM












Located at 616.81 TAY












Located at 616.8526 LAS

Wednesday, 7 October 2015

Friday, 1 May 2015

Artificial Pancreas During Pregnancy - Breakthrough

A diabetic woman has become the first in the world to give birth naturally after using an artificial pancreas while pregnant, experts have said.
The new mother-of-two has Type 1 diabetes and wore the piece of kit throughout her pregnancy to produce insulin and prevent symptoms of the disease.
Three other mothers have previously given birth in Cambridge after using the device but by caesarean section.
An artificial pancreas device system (APDS) is a small portable piece of equipment designed to carry out the function of a healthy pancreas.
It helps to control blood glucose levels using digital communication technology to automate insulin delivery.
An APDS is worn on the body during pregnancy and has a continuous glucose monitor (CGM), a digital controller and an insulin pump.
Dr Helen Murphy, principal investigator of the study Ms Finlayson-Wilkins took part in, said Euan's arrival was an exciting step in the treatment of diabetes in pregnancy.
"Women who have diabetes in pregnancy face higher rates of birth defects, over-sized babies, pre-term delivery and stillbirth than other pregnant women," she said.
"Treating diabetes in pregnancy can be particularly challenging because hormone levels are constantly changing and blood sugars can be difficult to predict."
The results of the ongoing National Institute for Health Research's Closed Loop in Pregnancy study are due to be published later this year.
Its findings could mean the technology benefits more pregnant women with diabetes.

Friday, 17 April 2015

Study finds 24,000 could have undiagnosed Type 2 diabetes

The largest ever study into diabetes and cardiovascular risk in Ireland has found as many as 24,000 people could have undiagnosed diabetes.
It found that 17% of people were found to have abnormal initial fasting blood sugar levels.
Men were found to be two to three times more likely than women to have abnormal blood sugar levels and undiagnosed diabetes.
Report author and Vhi Healthcare Medical Director Dr Bernadette Carr said: "The results of our research suggest that the rate of undiagnosed type 2 diabetes and pre-diabetes is higher in Ireland than in similar European countries such as Britain and Holland.
"They also demonstrate how important it is for individuals to understand and manage their own health risks.  
"By making some very simple lifestyle changes, people can improve their outcomes, and in the case of pre-diabetes can even delay or prevent progression to diabetes."
The research found that people with abnormal blood sugar levels were significantly more likely to be older, male, smokers and have higher blood pressure.
It said they were also less likely to exercise five days a week or eat fruit or vegetables each day.

Thursday, 2 April 2015

Office workers 'Too Sedentary'

Office workers need to get up and move around more, according to a new campaign in the UK - 'On Your Feet Britain'.
It says sitting for long periods at work is linked to a host of health problems, which are not undone by working out in the gym.  It is calling on people to stand regularly, walk around more and embrace ideas such as standing meetings or standing desks.

Experts described inactivity as "one of the biggest" challenges in health.

Heart disease, type 2 diabetes, cancers and poor mental health have all been linked to sedentary behaviour.

View Study here: Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults: A Systematic Review and Meta-analysisSedentary Time and Disease Incidence, Mortality, and Hospitalization

The effect is found even in people who class themselves as fit, such as those who cycle to work, if they also spend long periods of time sitting.

Prolonged sitting is thought to slow the metabolism and affect the way the body controls sugar levels, blood pressure and the breakdown of fat.

The campaign is a partnership between the group Get Britain Standing and the British Heart Foundation (BHF) charity.

Their survey of 2,000 office workers suggested:
  • 45% of women and 37% of men spend less than 30 minutes a day up on their feet at work
  • More than half regularly eat their lunch at their desk
  • 78% office workers felt they spent too much time sitting down
  • Nearly two-thirds were worried sitting at work was having a negative impact on their health
View more on BBC/Health here

Thursday, 12 February 2015

Does the future hold a vaccine for type 1 diabetes?

Mikael Knip (lower row, on right side)

The next decade could see the development of a vaccine for type 1 diabetes, which could be given to all infants or those with a genetic susceptibility to the disease, according to a world expert.

A leading Professor of Paediatrics from Finland has suggested there is “increasing evidence” that the diabetic enterovirus may be a trigger for type 1 diabetes in children. If this is confirmed, Prof Mikael Knip of the University of Helsinki believes it may be possible to prevent about half of new cases with an anti-diabetes enterovirus vaccine.


Speaking to Irish Medical Times at the third annual 3U Partnership International Diabetes Conference, which took place at the RCSI in Dublin recently, Prof Knip accepted there was still a long way to go. “We will not have an anti-diabetic entero vaccine available within the next five to six years, but maybe within the next 10 years,” he stated.
The professor is currently the Principal Investigator for two extensive international multicentre studies on type 1 diabetes. One is TRIGR (Trial to Reduce IDDM in the Genetically at Risk) testing the hypothesis that weaning to an extensively hydrolysed formula will reduce the frequency of beta-cell autoimmunity and type 1 diabetes in children at risk. This trial is mainly funded by the National Institutes of Health (NIH).
Prof Knip addressed the 3U diabetes conference in a talk entitled ‘Current challenges in diabetes research’ on his work to date on the prevention of type 1 diabetes in children.

Wednesday, 11 February 2015

'Smart' insulin hope for diabetes

Scientists are hopeful that "smart" insulins which are undergoing trials could revolutionise the way diabetes is managed.
Instead of repeated blood tests and injections throughout the day to keep blood sugar in check, a single dose of smart insulin would keep circulating in the body and turn on when needed.
Animal studies show the technology appears to work - at least in mice.
Scientists plan to move to human trials soon, PNAS journal reports.
Experts caution that it will take years of testing before treatments could become a reality for patients.
Dr Danny Chou from the Massachusetts Institute of Technology has been testing a smart insulin that he and his colleagues developed in the lab.
It is a chemically modified version of regular, long-acting insulin.
It has an extra set of molecules stuck on the end that binds it to proteins that circulate in the bloodstream. While it is attached to these, the smart insulin is in its switched off mode.
When blood sugar rises, the smart insulin switches on - glucose locks on to the smart insulin and tells it to get to work.
Dr Chou said: "My goal is to make life easier and safer for diabetics.
View more on BBC/Health here

Friday, 6 February 2015

Govt approves bill requiring calories on menus

The Cabinet has approved proposals requiring food outlets to post the information at the point where the food is ordered, whether at tables or counters.
Drafting legislation is expected to start immediately and should be ready for enactment by next year.
Minister for Health Leo Varadkar said the move is a simple but effective way of encouraging people to choose a healthier option.
"I am very concerned about levels of overweight and obesity in Ireland. Latest figures indicate that nearly two out of every three adults, and one in four children, are overweight or obese.
"This presents real risks for health and well-being and causes a high percentage of many of the chronic diseases like heart disease, cancer and diabetes," Minister Varadkar said.
The proposed laws will require all menus, including boards, leaflets, digital menus or other forms, to display the amount of calories alongside the price in the same font size and colour. 
View on RTE/Health here

Friday, 5 December 2014

Obesity can shorten life by eight years

Being obese can shorten life by eight years and condemn a person to almost two decades of ill-health, new research has shown.

Scientists used a computer model to predict that diabetes and heart disease were likely to deprive an obese person of up to 19 years of healthy living.

For the very obese, with a Body Mass Index (BMI) of 35 or more, between one and eight years of life were likely to be lost.

Overweight individuals with BMIs of 25 to 30 were predicted to have their lives shortened by up to three years.

BMI is calculated by dividing a person’s weight in kilograms by height in metres squared and is the standard tool used to define levels of obesity.  Someone who is obese is said to have a BMI of 30 or more.

Lead researcher Professor Steven Grover, from McGill University in Montreal, Canada, said: “Our computer modelling study shows that obesity is associated with an increased risk of developing cardiovascular disease (including heart disease and stroke) and diabetes that will, on average, dramatically reduce an individual’s life expectancy and the healthy life-years free from living with these chronic illnesses compared with people of normal weight.

“The pattern is clear.The more an individual weighs and the younger their age, the greater the effect on their health, as they have many years ahead of them during which the increased health risks associated with obesity can negatively impact their lives.”

The study, published in The Lancet Diabetes & Endocrinology journal, drew on data from the US National Health and Nutrition Examination Survey (NHANES).

Thursday, 4 December 2014

New DNA mapping project to discover causes of MND launched

Today sees the formal launch in Ireland of Project Mine, an ambitious international effort to find the genetic causes of motor neurone disease. It will involve scientists in 14 countries, including Ireland, who will collect patients’ DNA, sequence it and then do comparative studies that will help provide answers about this terrible disease.

Ireland sees 110 new cases of motor neurone disease every year, says Prof Orla Hardiman, who will lead Project Mine activity in Ireland. Scientists are still learning about the disease, but there is undoubtedly a genetic component, hence the need for an initiative such as this.

“The project is based on looking at the population genetics of motor neurone disease; whole genome association studies, ” says Hardiman, a professor of neurology at Trinity College Dublin and a consultant neurologist at Beaumont Hospital. “It is based on looking at genes, but being able to do this is all about computers, maths and statistics.”

“Ireland is a really good place to do this work; it is good for gene research. It can be easier to do these studies in Ireland because we have larger families and can compare family genes against the wider population.”

The complexity of the genetic background here is also lower than in a country such as the US or mainland Europe.

Only an international effort could tackle such a huge job, says Dr Russell McLaughlin, a postdoctoral research fellow in Trinity’s academic unit of neurology.The genetic resource created by the project will be important not just for motor neurone disease but for research into other conditions. McLaughlin is also involved in a study of irritable bowel syndrome, and the genetic information could be used to study multiple sclerosis, diabetes or Parkinson’s, says Hardiman.

Members of the consortium will share data freely, and so, although we will only pay for a part of the project, we will benefit from having access to all of the resultant data. “We get the data back,” says Vajda. “It is not giving genetic information away, it is bringing it back to us. It represents a new era in gene research. We need to be be involved. We need to be a partner in this to avoid missing out.”


Monday, 3 November 2014

NUI Galway Hold Free Foot Screening for World Diabetes Day


To mark World Diabetes Day on Friday, 14 November, NUI Galway will provide a free foot screening clinic from 1-4pm in the NUI Galway Podiatry Skills Laboratory on the third floor of Áras Moyola on campus.
Created in 1991, World Diabetes Day campaign is led by the International Diabetes Federation (IDF) and its member associations in response to growing concerns about the escalating health threat that diabetes now poses.
In Ireland, it remains unknown exactly how many people are currently living with diabetes. The Institute of Public Health’s report Making Diabetes Count estimated that there were about 143,000 people with diabetes in Ireland and predicted that this number would increase by 37%, to 194,000 people, by 2015.   
The Discipline of Podiatry at NUI Galway is the only School of Podiatry in the country and was established in 2008. Podiatry is a healthcare profession specialising in the management of disease and disorder of the lower limb and foot. Podiatrists are frequently involved in managing and treating individuals who are living with diabetes. For individuals who are living with diabetes – a number of diabetes related changes occur in the lower-limbs and ultimately this can affect the blood supply and the nerve supply to the feet.
The screening is strictly by appointment only. To schedule a 20 minute foot screening appointment email Dr Claire MacGilchrist at claire.macgilchrist@nuigalway.ie or 091 494265 before Tuesday, 11 November.

Friday, 22 August 2014

Irish Researchers Create Wearable Sensors Using Rubber Bands



Ordinary rubber bands could be transformed into wearable sensors for monitoring blood pressure, joint movement and blood glucose, as a result of a discovery by researchers at the AMBER materials science centre and Trinity College, Dublin.
The method involves adding graphene to the rubber bands, the first time this has ever been successfully achieved anywhere in the world.
Dubbed a wonder material, graphene is made from a single flat layer of carbon atoms.
It is super strong, flexible and conductive, and scientists believe it will in future be used to make all sorts of products, from flexible mobile phones to lighter aeroplanes.
But scientists at the AMBER materials science centre and the School of Physics at Trinity College Dublin have found another use.
In a paper published in the journal ACS Nano, they describe how adding graphene to shop-bought rubber bands, can transform them into wearable sensors.
The world first technique makes the rubber conduct electricity, without degrading its mechanical properties.
As the stretching of the bands strongly effects the flow of electrical current, the bands can sense tiny movements, like a pulse when attached to clothing for example.
The scientists say the discovery will lead to multiple uses in areas like healthcare, the automotive industry and robotics
The paper, Sensitive, High Strain, High-rate, bodily motion Sensors based on Graphene-Rubber Composites, is available here.

Wednesday, 20 August 2014

NUI Galway Public Forum on Diabetes

On Tuesday, 9 September NUI Galway will host a public forum on Diabetes, delving into what research is doing to help advance treatments for complications of Type 2 diabetes.Diabetes- It’s Complicated’ will take place in Room 243, Áras Moyola from 6.30-8.30pm.  
This free event is organised as part of the EU-funded project Repair of Diabetic Damage by Stromal Cell Administration (REDDSTAR), and co-ordinated by Professor Tim O’Brien, Dean of the College of Medicine, Nursing and Health Sciences at NUI Galway and Consultant Endocrinologist at Galway University Hospital.
Speakers include: NUI Galway’s Professor Tim O’ Brien, Dr Cynthia Coleman and Professor Caroline McIntosh; Dr Steve Elliman, Head of Research at Orbsen Therapeutics; Dr Donal O’Gorman, Centre for Preventative Medicine at Dublin City University and DEXLIFE; and Professor Noemi Lois of Queen’s University Belfast’s Centre for Experimental Medicine.
In conjunction with this event, a free foot screening will be offered from 3-5.30pm in the NUI Galway Podiatry Skills Laboratory on the third floor of Áras Moyola on campus. To schedule a 20 minute foot screening, please email REDDSTAR Dissemination Officer, Danielle Nicholson at Danielle.nicholson@orbsentherapeutics.com or 091 528778.